Cited by 62Epigenetics and DNA MethylationGenomics and Chromatin DynamicsChromatin Remodeling and Cancer

Correlation of DNA methylation with histone modifications across the HNRPA2B1-CBX3 ubiquitously-acting chromatin open element (UCOE)

Open access
Allen, Marianne Lindahl, Antoniou, Michael·2007·Epigenetics

Abstract

The methylation-free CpG island encompassing the divergently transcribed promoters of the HNRPA2B1 and CBX3 housekeeping genes possesses a dominant ubiquitously-acting chromatin opening element (UCOE) capability. This element allows reproducible and stable transgene expression including from within centromeric heterochromatin. We present an investigation of DNA methylation and histone modification marks across the HNRPA2B1-CBX3 locus in primary peripheral blood mononuclear cells (PBMCs) to characterise the chromatin structure that underlies UCOE activity. The CpG methylation-free region associated with the UCOE extends into the central areas of HNRPA2B1 and CBX3, with a total length of approximately 5 kb. However, the DNA in the 3' half of both genes is methylated. Histone H4 lysine (K) acetylation shows a broad distribution across both genes, whilst histone H3 lysine acetylation peaks around the transcriptional start sites and drops to background levels at the 3' ends. Higher levels of H3K4 di-methylation are present at the 3' end of the genes in contrast to H3K4 tri-methylation which peaks around the transcriptional start sites. Therefore, methylated DNA in transcribed regions of these genes has been shown here to co-exist with active histone modification marks, indicating that these functionally opposing epigenetic signatures can overlap. This suggests that an extended large region of unmethylated DNA in combination with distinct histone modification patterns are at the basis of UCOE function.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4161/epi.2.4.5231

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • An UCOE can prevent DNA methylation of the CMV promoter region, thus preventing gene expression silencing.

    “It has been shown that an UCOE can also prevent DNA methylation of the CMV promoter region, thus preventing gene expression silencing (Lindahl Allen and Antoniou, 2007;Zhang et al., 2010a).”

    From Therapeutic glycoprotein production in mammalian cells (2017) · cites this paper as Lindahl Allen and Antoniou, 2007

    The Introduction reports that the HNRPA2B1-CBX3 UCOE negates DNA-methylation-mediated silencing of hCMV-promoter-driven transgenes in stably transfected tissue-culture cells. It does not specifically say that the UCOE prevents methylation of the CMV promoter region; the paper’s own methylation analysis concerns the HNRPA2B1-CBX3 locus, not that promoter. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 35

  1. Fazzari MJ, Greally JM. Epigenomics: Beyond CpG islands. Nat Rev Genet 2004; 5:446-55.
  2. Gardiner-Garden M, Frommer M. CpG islands in vertebrate genomes. J Mol Biol 1987; 196:261-82.
  3. Antequera F, Bird A. Structure, function and evolution of CpG island promoters CpG islands as genomic footprints of promoters that are associated with replication origins. Cell Mol Life Sci 2003; 60:1647-58.
  4. Ponger L, Mouchiroud D. CpGProD: Identifying CpG islands associated with transcription start sites in large genomic mammalian sequences. Bioinformatics 2002; 18:631-3.
  5. �azi J, Bird A. Alternative chromatin structure at CpG islands. Cell 1990; 60:909-20.
  6. Brinkman AB, Pennings SW, Braliou GG, Rietveld LE, Stunnenberg HG. DNA methyla- tion immediately adjacent to active histone marking does not silence transcription. Nucleic Acids Res 2007; 35:801-11.
  7. Nakao M. Epigenetics: Interaction of DNA methylation and chromatin. Gene 2001; 278:25-31.
  8. Grunstein M. Histone acetylation in chromatin structure and transcription. Nature 1997; 389:349-52.
  9. Harland L, Crombie R, Anson S, deBoer J, Ioannou PA, Antoniou M. �ranscriptional regulation of the human �A�A binding protein gene. Genomics 2002; 79:479-82. ©
  10. L A N D E S B I O S C I E N C E . D O N O T D I S T R I B U T E . 10. Antoniou M, Harland L, Mustoe �, Williams S, Holdstock J, Yague E, Mulcahy �, Griffiths M, Edwards S, Ioannou PA, Mountain A, Crombie R. �ransgenes encompassing dual-promoter CpG islands from the human �BP and HNRPA2B1 loci are resistant to heterochromatin-mediated silencing. Genomics 2003; 82:269-79.
  11. Williams S, Mustoe �, Mulcahy �, Griffiths M, Simpson D, Antoniou M, Irvine A, Mountain A, Crombie R. CpG-island fragments from the HNRPA2B1/CBX3 genomic locus reduce silencing and enhance transgene expression from the hCMV promoter/enhanc- er in mammalian cells. BMC Biotechnol 2005; 5:17.
  12. Zhang F, �hornhill SI, Howe SJ, Ulaganathan M, Axel Schambach A, Sinclair J, Kinnon C, Gaspar HB, Antoniou M, �hrasher AJ. Lentiviral vectors containing an enhancer-less ubiquitously-acting chromatin opening element (UCOE) provide highly reproducible and stable transgene expression in haematopoietic cells. Blood 2007, 110:1448-57.
  13. Bernstein BE, Kamal M, Lindblad-�oh K, Bekiranov S, Bailey DK, Huebert DJ, McMahon S, Karlsson EK, Kulbokas IIIrd EJ, Gingeras �R, Schreiber SL, Lander ES. Genomic maps and comparative analysis of histone modifications in human and mouse. Cell 2005; 120:169-81.
  14. Baguet A, Bix M. Chromatin landscape dynamics of the Il4-Il13 locus during � helper 1 and 2 development. Proc Natl Acad Sci USA 2004; 101:11410-5.
  15. Szutorisz H, Canzonetta C, Georgiou A, Chow CM, �ora L, Dillon N. Formation of an active tissue-specific chromatin domain initiated by epigenetic marking at the embryonic stem cell stage. Mol Cell Biol 2005; 25:1804-20.
  16. O'Neill LP, �urner BM. Immunoprecipitation of native chromatin: NChIP. Methods 2003; 31:76-82.
  17. Cross SH, Bird AP. CpG islands and genes. Curr Opin Genet Dev 1995; 5:309-14.
  18. Cross SH, Clark VH, Bird AP. Isolation of CpG islands from large genomic clones. Nucleic Acids Res 1999; 27:2099-107.
  19. Clark SJ, Statham A, Stirzaker C, Molloy PL, Frommer M. DNA methylation: Bisulphite modification and analysis. 2006; 1:2353-64.
  20. Smiraglia DJ, Rush LJ, Fruhwald MC, Dai Z, Held WA, Costello JF, Lang JC, Eng C, Li B, Wright FA, Caligiuri MA, Plass C. Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies. Hum Mol Genet 2001; 10:1413-9.
  21. Zilberman D, Gehring M, �ran RK, Ballinger �, Henikoff S. Genome-wide analysis of Arabidopsis thaliana DNA methylation uncovers an interdependence between methylation and transcription. Nat Genet 2007; 39:61-9.
  22. Hellman A, Chess A. Gene body-specific methylation on the active X chromosome. Science 2007; 315:1141-3.
  23. �akai D, Jones PA. Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc Natl Acad Sci USA 2002; 99:3740-5.
  24. Appanah R, Dickerson DR, Goyal P, Groudine M, Lorincz MC. An unmethylated 3' promoter-proximal region is required for efficient transcription initiation. PLoS Genet 2007; 3:27.
  25. Kozu �, Henrich B, Schafer KP. Structure and expression of the gene (HNRPA2B1) encod- ing the human hnRNP protein A2/B1. Genomics 1995; 25:365-71.
  26. Sueoka E, Goto Y, Sueoka N, Kai Y, Kozu �, Fujiki H. Heterogeneous nuclear ribonucleo- protein B1 as a new marker of early detection for human lung cancers. Cancer Res 1999; 59:1404-7.
  27. Zech VF, Dlaska M, �zankov A, Hilbe W. Prognostic and diagnostic relevance of hnRNP A2/B1, hnRNP B1 and S100 A2 in non-small cell lung cancer. Cancer Detect Prev 2006; 30:395-402.
  28. Jones PA. Altering gene expression with 5-azacytidine. Cell 1985; 40:485-6.
  29. Liang G, Lin JCY, Wei V, Yoo C, Cheng JC, Nguyen C�, Weisenberger DJ, Egger G, �akai D, Gonzales FA, Jones PA. Distinct localization of histone H3 acetylation and H3-K4 meth- ylation to the transcription start sites in the human genome 10.1073/pnas.0401866101. PNAS 2004; 101:7357-62. · DOI
  30. Myers FA, Evans DR, Clayton AL, �horne AW, Crane-Robinson C. �argeted and extended acetylation of histones H4 and H3 at active and inactive genes in chicken embryo erythro- cytes. J Biol Chem 2001; 276:20197-205.
  31. Myers FA, Chong W, Evans DR, �horne AW, Crane-Robinson C. Acetylation of histone H2B mirrors that of H4 and H3 at the chicken beta-globin locus but not at housekeeping genes. J Biol Chem 2003; 278:36315-22.
  32. Agricola E, Verdone L, Di Mauro E, Caserta M. H4 acetylation does not replace H3 acetylation in chromatin remodelling and transcription activation of Adr1-dependent genes doi:10.1111/j.1365-2958.2006.05451.x. Mol Microbiol 2006; 62:1433-46. · DOI
  33. Vignali M, Steger DJ, Neely KE, Workman JL. Distribution of acetylated histones resulting from Gal4-VP16 recruitment of SAGA and NuA4 complexes. EMBO J 2000; 19:2629-40.
  34. Heintzman ND, Stuart RK, Hon G, Fu Y, Ching CW, Hawkins RD, Barrera LO, Van Calcar S, Qu C, Ching KA, Wang W, Weng Z, Green RD, Crawford GE, Ren B. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet 2007; 39:311-8.
  35. Schneider R, Bannister AJ, Myers FA, �horne AW, Crane-Robinson C, Kouzarides �. Histone H3 lysine 4 methylation patterns in higher eukaryotic genes. Nat Cell Biol 2004; 6:73-7.

Cited by

Sorted by citations

Authors
Allen, M. L., & Antoniou, M.
Venue
Epigenetics
Published
2007-10-03
Volume
2
Issue
4
Pages
227-236
ISSN
  • 1559-2294 (ISSN-L)
  • 1559-2308
OpenAlex
W2057407754
Cited by
62
References
1
Citations by year
2025: 4 · 2023: 2 · 2022: 1 · 2020: 1 · 2019: 3 · 2018: 4 · 2017: 8 · 2015: 5 · 2014: 5 · 2013: 7 · 2012: 3
FWCI
1.98
Type
journal article
Language
en
Open access
Locations
  • Epigenetics (publishedVersion)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (submittedVersion)
Funders
Medical Research Council
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
Keywords
DNA methylation, histone modifications, CBX3, CpG islands, divergent transcription, H3K4 dimethylation, H3K4 trimethylation, centromeric heterochromatin, transgene expression, epigenetic signatures, peripheral blood mononuclear cells
MeSH terms
Acetylation, Cells, Cultured, Chromatin, Chromosomal Proteins, Non-Histone, Histones, Humans, Monocytes, Promoter Regions, Genetic, CpG Islands, DNA Methylation, Reverse Transcriptase Polymerase Chain Reaction, Heterogeneous-Nuclear Ribonucleoprotein Group A-B, Chromatin Immunoprecipitation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review